Figure 2From: Optimal designs for population pharmacokinetic studies of the partner drugs co-administered with artemisinin derivatives in patients with uncomplicated falciparum malariaStructural pharmacokinetic models considered for the lumefantrine, piperaquine and desethylamodiaquine optimal designs, with parameter values set to the reported population estimates. The optimal sampling windows are displayed on the time axes.Back to article page